Showing results (101-110 of 197) with videos related to
Sort By:
Pageof 20
Dermatology and Therapy|May 9, 2024
Brodalumab: 5-Year US Pharmacovigilance ReportMark G Lebwohl, John Y Koo, April W Armstrong, et al.The Journal of Dermatological Treatment|September 14, 2007
Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) studyAlice B Gottlieb, Leon Kircik, Drore Eisen, et al.Archives of Dermatology|February 20, 2008
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.Journal of Drugs in Dermatology : JDD|August 7, 2025
Two-Year Treatment Persistence of Guselkumab vs Other Biologics in Plaque Psoriasis PatientsBruce E Strober, Jud C Janak, Timothy Fitzgerald, et al.Seminars in Cutaneous Medicine and Surgery|July 27, 2017
Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™Kenneth B Gordon, Craig L Leonardi, Daniel E Furst, et al.Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.Archives of Dermatology|June 20, 2007
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasisStephen Tyring, Kenneth B Gordon, Yves Poulin, et al.The Journal of Dermatological Treatment|March 17, 2007
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activityAmir A Toor, Patrick J Stiff, Brian J Nickoloff, et al.Journal of the American Academy of Dermatology|November 23, 2006
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasisAngela Moore, Kenneth B Gordon, Sewon Kang, et al.Cutis|May 16, 2007
Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATEEllen H Frankel, Bruce E Strober, Jeffrey J Crowley, et al.Pageof 20